Transaction · 0001938861-26-000028

Cook Meredith

Cook Meredith, SV, GC, SEC, reported an open-market or private sale at ANI PHARMACEUTICALS INC involving 500.000000 shares for an estimated $36795.00. Reported holdings after the transaction were 73424.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSV, GC, SEC
ANIPANI PHARMACEUTICALS INC
Trade date
Oct 13, 2026
Filing date
Oct 14, 2026
View on SEC Insider profile
Estimated value-$36.7kShares × reported price
Shares traded500$73.59 per share
Holdings after73.4kDirect
% of reported position traded0.68%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 73,924 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ANIP price since this filing

Daily closing prices, with the filing date and available return windows
ANIP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.9%1w ago +1.0%1d ago +3.9%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001938861-26-000028
Common Stock
Transaction date
Oct 13, 2026
Filed Oct 14, 2026, 12:47 AM · 1d delay
Shares
500 sh
$73.59 per share
Estimated value
-$36.7k
Computed from shares × price
Holdings after
73,424 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SR. VP, GENERAL COUNSEL & SEC.

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.

Original filing · 0001938861-26-000028
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ANIP